Clinical Trials Directory

Trials / Terminated

TerminatedNCT03085394

Preoperative Hexakapron Reduces Bleeding in Bariatric Surgery

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
152 (actual)
Sponsor
Sheba Medical Center · Other Government
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Prophylactic use of tranexamic acid to reduce intra and postoperative bleeding in primary sleeve gastrectomy procedures will be studied.

Detailed description

Patients scheduled for primary laparoscopic sleeve gastrectomy for the treatment of morbid obesity will be assigned to receive tranexamic acid vs. placebo before surgery. Intraoperative bleeding will be scored, as well as postoperative bleeding and blood or blood-product requirements. POstoperative venous thromboembolic events will be recorded up to 2 months following surgery.

Conditions

Interventions

TypeNameDescription
DRUGtranexamic acidPreoperative intravenous administration of 2 grams tranexamic acid in 10 ml saline
DRUGPlaceboPreoperative intravenous administration of 10 ml saline

Timeline

Start date
2017-09-01
Primary completion
2022-11-21
Completion
2022-11-21
First posted
2017-03-21
Last updated
2023-04-19

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT03085394. Inclusion in this directory is not an endorsement.